Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L De Haan

Showing results (91-100 of 129) with videos related to

Pageof 13
Sort By:
Tijdschrift Voor Psychiatrie|October 28, 2024
[Back space in regulations: legal frameworks of research with existing patient data]M B de Koning, T J Burger, A Vellinga, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|April 20, 2001
Preferences for treatment during a first psychotic episodeL de Haan, B van Raaij, R van den Berg, et al.
Journal of Psychopharmacology (Oxford, England)|December 10, 2015
Cue-induced striatal activity in frequent cannabis users independently predicts cannabis problem severity three years laterW A M Vingerhoets, L Koenders, W van den Brink, et al.
Psychological Medicine|November 18, 2009
Implicit and explicit affective associations towards cannabis use in patients with recent-onset schizophrenia and healthy controlsN Dekker, A M Smeerdijk, R W Wiers, et al.
Acta Psychiatrica Scandinavica|April 17, 2015
Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysisA L Sutterland, G Fond, A Kuin, et al.
Schizophrenia Research|February 12, 2025
Skin advanced glycation end products, indicating cumulative oxidative stress, associated with schizophrenia but not with psychosis-like experiencesJ M Hagen, A Cornelissen, R R Veeneman, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 19, 2026
Influence of Age and Gender on Short-Term Efficacy, Acceptability and Safety of Antipsychotic Drug Treatment of Adolescents With Schizophrenia: An Individual Patient Data Meta-AnalysisBram W C Storosum, Sem E Cohen, Nynke Tilkema, et al.
Psychological Medicine|July 5, 2014
Adapted cognitive-behavioural therapy required for targeting negative symptoms in schizophrenia: meta-analysis and meta-regressionE Velthorst, M Koeter, M van der Gaag, et al.
International Journal of Geriatric Psychiatry|January 16, 2013
Theory of Mind differences in older patients with early-onset and late-onset paranoid schizophreniaM M J Smeets-Janssen, P D Meesters, H C Comijs, et al.
Psychological Medicine|February 6, 2010
Neurocognitive functioning before and after the first psychotic episode: does psychosis result in cognitive deterioration?H E Becker, D H Nieman, S Wiltink, et al.
Pageof 13

Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
Tijdschrift Voor Psychiatrie|October 28, 2024
[Back space in regulations: legal frameworks of research with existing patient data]M B de Koning, T J Burger, A Vellinga, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|April 20, 2001
Preferences for treatment during a first psychotic episodeL de Haan, B van Raaij, R van den Berg, et al.
Journal of Psychopharmacology (Oxford, England)|December 10, 2015
Cue-induced striatal activity in frequent cannabis users independently predicts cannabis problem severity three years laterW A M Vingerhoets, L Koenders, W van den Brink, et al.
Psychological Medicine|November 18, 2009
Implicit and explicit affective associations towards cannabis use in patients with recent-onset schizophrenia and healthy controlsN Dekker, A M Smeerdijk, R W Wiers, et al.
Acta Psychiatrica Scandinavica|April 17, 2015
Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysisA L Sutterland, G Fond, A Kuin, et al.
Schizophrenia Research|February 12, 2025
Skin advanced glycation end products, indicating cumulative oxidative stress, associated with schizophrenia but not with psychosis-like experiencesJ M Hagen, A Cornelissen, R R Veeneman, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 19, 2026
Influence of Age and Gender on Short-Term Efficacy, Acceptability and Safety of Antipsychotic Drug Treatment of Adolescents With Schizophrenia: An Individual Patient Data Meta-AnalysisBram W C Storosum, Sem E Cohen, Nynke Tilkema, et al.
Psychological Medicine|July 5, 2014
Adapted cognitive-behavioural therapy required for targeting negative symptoms in schizophrenia: meta-analysis and meta-regressionE Velthorst, M Koeter, M van der Gaag, et al.
International Journal of Geriatric Psychiatry|January 16, 2013
Theory of Mind differences in older patients with early-onset and late-onset paranoid schizophreniaM M J Smeets-Janssen, P D Meesters, H C Comijs, et al.
Psychological Medicine|February 6, 2010
Neurocognitive functioning before and after the first psychotic episode: does psychosis result in cognitive deterioration?H E Becker, D H Nieman, S Wiltink, et al.
Pageof 13